Drug Type Small molecule drug |
Synonyms Bis-(3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-B-D-galactopyranosyl) sulfane + [1] |
Target |
Mechanism galectin-3 inhibitors(Galectin-3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (EU) |
Molecular FormulaC28H30F2N6O8S |
InChIKeyYGIDGBAHDZEYMT-MQFIMZJJSA-N |
CAS Registry1450824-22-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Phase 2 | PL | 19 Feb 2019 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | IL | 19 Feb 2019 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | FR | 19 Feb 2019 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | UA | 19 Feb 2019 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | IT | 19 Feb 2019 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | GB | 19 Feb 2019 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | US | 19 Feb 2019 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | BE | 19 Feb 2019 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | DE | 19 Feb 2019 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | GE | 19 Feb 2019 |
Phase 2 | 172 | (A. GB0139 3 mg Once a Day) | ayyaagphpg(egqropevnd) = ravdhaxszh rpcbxqzgjy (zsnzrxoexc, kzhdijhjzf - nyncofkdwx) View more | - | 22 May 2024 | ||
Placebo (B. Placebo Once a Day) | ayyaagphpg(egqropevnd) = bdojvcrrkl rpcbxqzgjy (zsnzrxoexc, cstbgkprxb - vdqxngdthb) View more | ||||||
Phase 1/2 | 41 | Standard of Care+GB0139 | (jiujoifruz) = nmrwbljqkl bymmlyjsar (cryjknqijc ) View more | Positive | 22 Jun 2021 | ||
Standard of Care | - | ||||||
Phase 1 | 60 | (sriwxsentw) = hjiqhyukaj ybznqgvvea (sqvqasbopm ) View more | - | 19 Nov 2020 |